These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2433019)

  • 1. Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy.
    Torti FM; Lum BL
    Cancer; 1987 Feb; 59(3 Suppl):613-6. PubMed ID: 2433019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical therapy of bladder cancer: an immunotherapy success story.
    Morales A
    Int J Urol; 1996 Sep; 3(5):329-33. PubMed ID: 8886906
    [No Abstract]   [Full Text] [Related]  

  • 7. Superficial carcinoma of the bladder: natural history and the role of interferons.
    Torti FM; Lum BL
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):57-60. PubMed ID: 3532337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological analysis of high-grade superficial bladder tumour.
    Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Ishii N; Kawamura S; Nakada T; Suzuki K
    Int Urol Nephrol; 1991; 23(3):237-43. PubMed ID: 1889970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ
    Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of intravesical therapy for superficial bladder cancer.
    Lamm DL
    Urol Clin North Am; 1992 Aug; 19(3):573-80. PubMed ID: 1636241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical data in bladder cancer immunotherapy with Connaught BCG (ImmuCyst).
    Barreto L; Csizer Z; Sparkes JD
    Dev Biol Stand; 1992; 77():229-31. PubMed ID: 1426667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant therapy modalities].
    Lampel A; Thüroff JW
    Urologe A; 1998 Jan; 37(1):93-101. PubMed ID: 9540194
    [No Abstract]   [Full Text] [Related]  

  • 14. Approaches to the treatment of bladder cancer at Stanford.
    Torti FM
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S63-6. PubMed ID: 2444355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical therapy: does it affect the natural history of superficial bladder cancer?
    Lamm DL; Griffith JG
    Semin Urol; 1992 Feb; 10(1):39-44. PubMed ID: 1565903
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical management of superficial bladder cancer (stages Ta/T1/CIS).
    Smith JA
    Semin Surg Oncol; 1997; 13(5):328-34. PubMed ID: 9259088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial bladder cancer: survival and prognostic factors.
    Sánchez de la Muela P; Rosell D; Agüera L; De Castro F; Isa W; Robles JE; Zudaire JJ; Berián JM
    Eur Urol; 1991; 20(3):184-91. PubMed ID: 1823040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of superficial bladder cancer.
    Pow-Sang JM; Seigne JD
    Cancer Control; 2000; 7(4):335-9. PubMed ID: 10895127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical interferon alfa in the treatment of superficial bladder cancer.
    Williams RD
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):10-3. PubMed ID: 3057641
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.